Lyon, France

Adocia


USPTO Granted Patents = 43

% Expired Patents = 32.6


Trademarks = 3

Forward Citations = 86

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Olivier Soula (24 out of 33 patents)

silverMedal Richard Charvet (20 out of 20 patents)

bronzeMedal Alexandre Geissler (13 out of 13 patents)

4.  Remi Soula (13 out of 13 patents)

5.  You-Ping Chan (9 out of 41 patents)

6.  Gerard Soula (9 out of 61 patents)

7.  Romain Noel (8 out of 8 patents)

8.  Nicolas Laurent (8 out of 8 patents)

9.  Gérard Soula (6 out of 14 patents)

10.  Bertrand Alluis (5 out of 5 patents)

11.  David Duracher (5 out of 5 patents)

12.  Grégory Meiffren (4 out of 4 patents)

13.  Walter Roger (3 out of 3 patents)

14.  Emmanuel Dauty (3 out of 3 patents)

15.  Ségolène Laage (3 out of 3 patents)


Core Competencies:
Insulin Compositions
Hydrogels
Aqueous Solutions
Amylin Analogues
Polysaccharides
Fast-Acting Insulin
Co-Polyamino Acids
Glucagon
Viscosity Reduction
Anionic Compounds
Protein Complexes
Substituted Oligosaccharides

43 patents:

Adocia is a biotechnology company based in Lyon, France, specializing in the development of innovative therapeutic solutions for diabetes and other metabolic diseases. The company focuses on advanced drug delivery systems, particularly hydrogels and injectable solutions, to enhance the efficacy of insulin therapies. Adocia's research encompasses various technology domains, including amylin analogues, basal and rapid-acting insulin formulations, human glucagon, and co-polyamino acids, aiming to improve patient outcomes through novel treatment approaches.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Adocia
43 Patents

#9 in Lyon

#541 in France

#16,010 in the World

Lyon, FR
Lyon, France
Forward Citations = 86

25 inventors:

Please report any incorrect information to [email protected]
Loading…